Doctor profile · Federal record
Dr. Jason Ballin, D.O.
Dermatology Physician (CMS: Dermatology) · Dayton, OH
- NPI 1235293820
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 20 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
5300 Far Hills Ave
Dayton, OH 454292381
(937) 312-3820 - Additional location
-
4020 Copper Vw Ste 130
Traverse City, MI 496847041
(231) 941-4114
fax (231) 941-0878 - Mailing address
-
45 Stanfield RD.
Troy, OH 453732366
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- July 22, 2025
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Ohio #34.012702
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1235293820. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
14,979
Distinct HCPCS
10
Medicare allowed
$792,778
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 5,467 | 727 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 2,652 | 1,200 | $86 | |
17110 |
Destruction of skin growth, 1-14 growths | 1,839 | 1,072 | $100 | |
17000 |
Destruction of precancer skin growth, 1 growth | 1,563 | 897 | $35 | |
11300 |
Shaving of skin growth of body, arms, or legs, 0.5 cm or less | 800 | 489 | $50 | |
11102 |
Biopsy of related skin growth, first growth | 757 | 566 | $54 | |
11103 |
Biopsy of related skin growth, each additional growth | 291 | 177 | $47 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 209 | 160 | $159 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 149 | 116 | $151 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 137 | 59 | $1 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 304. This provider delivers 49× the peer median.Open Payments
Industry payments received
All-time total
$1,281
Transactions
70
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 16 | $346.56 | |
| ABBVIE INC. | 26 | $324.17 | |
| GENZYME CORPORATION | 10 | $234.56 | |
| Novartis Pharmaceuticals Corporation | 6 | $105.23 | |
| Amgen Inc. | 3 | $78.08 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $56.27 | |
| PFIZER INC. | 2 | $39.43 | |
| Janssen Biotech, Inc. | 1 | $34.76 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24.41 | |
| UCB, Inc. | 1 | $23.54 | |
| Dermavant Sciences, Inc. | 1 | $14.34 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,450
Patients
1,513
Total drug cost
$68,950
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Mupirocin | Generic | 405 | 342 | $3,905 |
| Triamcinolone Acetonide | Generic | 260 | 185 | $2,948 |
| Clobetasol Propionate | Generic | 255 | 136 | $20,501 |
| Doxycycline Hyclate | Generic | 195 | 147 | $4,579 |
| Finasteride | Generic | 194 | 56 | $1,529 |
| Hydrocortisone | Generic | 194 | 130 | $1,451 |
| Ketoconazole | Generic | 194 | 107 | $3,494 |
| Hydroxyzine Hcl | Generic | 132 | 63 | $1,799 |
| Fluocinolone Acetonide | Generic | 127 | 90 | $7,872 |
| Spironolactone | Generic | 106 | 0 | $1,115 |
Frequently asked questions
What is Dr. Jason Ballin's medical specialty?
Dr. Jason Ballin practices Dermatology Physician in Dayton, OH.
Where does Dr. Jason Ballin practice?
Dr. Jason Ballin practices at 5300 Far Hills Ave, Dayton, OH 454292381. Office phone: 9373123820.
What is Dr. Jason Ballin's NPI?
Dr. Jason Ballin's National Provider Identifier (NPI) is 1235293820, issued by NPPES.
Does Dr. Jason Ballin accept Medicare assignment?
Yes. Dr. Jason Ballin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jason Ballin commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.